GSK (GSK) Earnings Date, Estimates & Call Transcripts $37.14 -0.36 (-0.97%) As of 10:14 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock GSK Earnings Summary Latest Q1 Earnings DateApr. 30EstimatedConsensus EPS (Apr. 30) $1.08 Actual EPS (Apr. 30) $1.13 Beat By $0.05 Actual Revenue (Apr. 30) $10.06BGSK announced Q1 2025 earnings on April 30, 2025, reporting an EPS of $1.13, which beat analysts' consensus estimates of $1.08 by $0.05. Quarterly revenue rose 2.1% year-over-year to $10.06 billion, above analyst estimates of $7.52 billion. With a trailing EPS of $1.94 and a P/E Ratio of 23.42, GSK's earnings are expected to grow 12.32% next year, from $4.14 to $4.65 per share. Q1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Interim Report Slide DeckSlide DeckFull Screen Slide DeckPowered by Get GSK Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on GSK and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataGSK Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.GSK Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. GSK Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany EPS GuidanceCompany Revenue GuidanceQ1 20251$1.03$1.03$1.03Q2 20251$1.05$1.05$1.05Q3 20251$1.24$1.24$1.24Q4 20251$0.76$0.76$0.76 FY 2025 4 $4.08 $4.08 $4.08 Q1 20261$1.05$1.05$1.05Q2 20261$1.10$1.10$1.10Q3 20261$1.48$1.48$1.48 2026 3 $3.63 $3.63 $3.63 Q1 20271$1.07$1.07$1.07 GSK Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails4/30/2025Q1 2025$1.08$1.13+$0.05$1.00$7.52B$10.06B2/5/2025Q4 2024$0.44$0.59+$0.15$0.26$7.75B-7/31/2024Q2 2024$1.00$1.09+$0.09$1.46$9.49B$9.95B5/1/2024Q1 2024$0.94$1.09+$0.15$1.53$8.98B$9.34B1/31/2024Q4 2023$0.76$0.72 -$0.04$1.23$9.79B$10.00B11/1/2023Q3 2023$1.09$1.26+$0.17$1.62$9.72B$10.32B7/26/2023Q2 2023$0.85$0.97+$0.12$0.94$8.49B$8.98B GSK Earnings - Frequently Asked Questions When did GSK announce their last quarterly earnings? GSK (NYSE:GSK) last announced its quarterly earning data on Wednesday, April 30, 2025. Learn more on GSK's earnings history. What guidance has GSK issued on next quarter's earnings? GSK issued an update on its FY 2025 earnings guidance on Wednesday, April, 30th. The company provided earnings per share guidance of 4.250-4.590 for the period, compared to the consensus earnings per share estimate of 4.360. The company issued revenue guidance of $40.7 billion-$42.7 billion, compared to the consensus revenue estimate of $32.6 billion. Did GSK beat their earnings estimates last quarter? In the previous quarter, GSK (NYSE:GSK) reported $1.13 earnings per share (EPS) to beat the analysts' consensus estimate of $1.08 by $0.05. Learn more on analysts' earnings estimate vs. GSK's actual earnings. How can I listen to GSK's earnings conference call? The conference call for GSK's latest earnings report can be listened to online. Listen to Conference Call How can I read GSK's conference call transcript? The conference call transcript for GSK's latest earnings report can be read online. Read Transcript How much revenue does GSK generate each year? GSK (NYSE:GSK) has a recorded annual revenue of $31.53 billion. How much profit does GSK generate each year? GSK (NYSE:GSK) has a recorded net income of $3.29 billion. GSK has generated $1.94 earnings per share over the last four quarters. What is GSK's price-to-earnings ratio? GSK (NYSE:GSK) has a trailing price-to-earnings ratio of 23.58 and a forward price-to-earnings ratio of 9.06. The price/earnings-to-growth ratio is 1.12. What is GSK's EPS forecast for next year? GSK's earnings are expected to grow from $4.14 per share to $4.65 per share in the next year, which is a 12.32% increase. More Earnings Resources from MarketBeat Related Companies Novo Nordisk A/S Earnings Results Novartis Earnings Results AstraZeneca Earnings Results Sanofi Earnings Results Takeda Pharmaceutical Earnings Results argenx Earnings Results Beigene Earnings Results BioNTech Earnings Results Summit Therapeutics Earnings Results Teva Pharmaceutical Industries Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Archer Stock Eyes Q1 Earnings After UAE UpdatesFord Motor Stock Rises After Earnings, But Momentum May Not Last Broadcom Stock Gets a Lift on Hyperscaler Earnings & CapEx BoostPalantir Stock Drops Despite Stellar Earnings: What's Next?Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?Is Reddit Stock a Buy, Sell, or Hold After Earnings Release?Warning or Opportunity After Super Micro Computer's Earnings This page (NYSE:GSK) was last updated on 5/7/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredVirtually Limitless Energy?A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discov...Stansberry Research | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GSK plc Please log in to your account or sign up in order to add this asset to your watchlist. Share GSK With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GSK Stock Free GSK Stock Alerts